An official website of the United States government
Here's how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Brought to you by the Council of the Inspectors General on Integrity and Efficiency
Our objective was to evaluate whether virtual private network (VPN) access to the Postal Service’s Information Technology (IT) network was granted only to those individuals who require access. eAccess is used for requesting and approving access for applications and other IT infrastructure. We reviewed eAccess data that showed authorizations for Postal Service contractors and employees who have been granted VPN access.
The productivity of the Postal Service varies significantly around the country. The principal factors we examined affecting productivity were weather, cost of living, and terrain ruggedness. Identifying other factors causing productivity to vary around the country could give the Postal Service opportunities to pinpoint and address them.
OIG administers the Medicaid Fraud Control Unit (MFCU or Unit) grant awards, annually recertifies the Units, and oversees the Units' performance in accordance with the requirements of the grant. As part of this oversight, OIG conducts periodic reviews of all Units and prepares public reports based on these reviews.
Financial Audit of the Ghar Ghar Maa Swasthya Program Managed by Nepal CRS Company Pvt. Ltd., Cooperative Agreement AID-367-A-10-00002, July 16, 2017, to July 16, 2018
Connecticut did not always comply with Federal Medicaid requirements for invoicing manufacturers for rebates for physician-administered drugs. Connecticut did not invoice manufacturers for rebates associated with $1.1 million (Federal share) in physician-administered drugs. Of this amount, $1.07 million was for single-source drugs, and $46,210 was for top-20 multiple-source drugs. Further, Connecticut did not submit the utilization data necessary to secure rebates for all other physician-administered drug claims totaling $2.8 million (Federal share).
